Arcellx (ACLX) Treasury Shares (2021 - 2025)
Arcellx's (ACLX) quarterly Treasury Shares came in at $2.1 million in Q4 2025, up 15.86% year-on-year from $1.8 million in Q4 2024, and up 15.86% quarter-over-quarter from $1.8 million in Q4 2024.
Arcellx (ACLX) Treasury Shares (2021 - 2025) Analysis & Trends
Arcellx's Treasury Shares history runs 5 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- On a quarterly basis, Treasury Shares rose 15.86% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 15.86% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 15.86% from the prior year.
- Treasury Shares improved to $2.1 million in Q4 2025 per ACLX's latest filing, from $1.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $10.4 million in Q3 2021 and bottomed at $881624.0 in Q3 2022.
- The 5-year median for Treasury Shares is $2.0 million (2024), against an average of $4.0 million.
- Across the five-year window, Treasury Shares plunged 91.52% in 2022 and jumped 611.11% in 2023, its largest moves.
- Year by year, Treasury Shares stood at $9.0 million in 2021, then slumped by 89.38% to $952804.0 in 2022, then soared by 48.66% to $1.4 million in 2023, then grew by 27.91% to $1.8 million in 2024, then climbed by 15.86% to $2.1 million in 2025.
- Per Business Quant, the three latest ACLX Treasury Shares figures stand at $2.1 million (Q4 2025), $1.8 million (Q4 2024), and $1.4 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 6.27 Mn |
| Sep 30, 2023 | 6.27 Mn |
| Jun 30, 2023 | 952,804.00 |
| Jun 30, 2023 | 952,804.00 |
| Mar 31, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 952,804.00 |
| Dec 31, 2022 | 952,804.00 |
| Sep 30, 2022 | 881,624.00 |
| Sep 30, 2022 | 881,624.00 |
| Jun 30, 2022 | 952,804.00 |
| Jun 30, 2022 | 952,804.00 |
| Mar 31, 2022 | 6.27 Mn |
| Mar 31, 2022 | 6.27 Mn |